EMJ GOLD

Hideki Garren explores how our understanding of MS is evolving, the challenge of measuring disease progression and what the future holds.

Predictions you won’t want to miss from industry experts. Unpack opportunities, threats and unknowns.

Hear from three expert voices in an end-of-year round-up as they reflect on the moments that shaped healthcare and life sciences in 2025.

This week, Isabel sits down with Carol Pitcher-Towner, Alnylam, to unpack the gender inequities that continue to shape modern healthcare.

Isabel is joined by Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, for a deep dive into the current and future Alzheimer’s landscape.

Giuseppe Savoja, Medtronic, is on the show to talk about the evolution and future of ECMO, plus the evolving needs of intensive care units.

Theramex’s CEO discusses the role men must play in improving women’s health, the importance of breaking taboos and why funding is key.

Listen in to the standout moments from EMJ GOLD’s guests this season, uncovering the challenges and opportunities shaping today’s pharmaceutical industry.

Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in radiology today.

AbbVie’s Daejin Abidoye reflects on his 20-year journey in oncology – from clinical insights to advances in precision medicine in the cancer space.

What is the environmental cost of respiratory illness? In this episode, Shish Patel, Medical Director, Chiesi UK joins Isabel to explore this and COPD’s rising burden.

Matt Mortimer Ryan, GSK, discusses how understanding patients’ emotional drivers can unlock more impactful pharma marketing campaigns.

Dive into the latest insights from EMJ GOLD’s contributors to uncover what HCPs really want from medical affairs in 2025.

Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, explores how the UK is shaping access to medicine.

This National Blood Week, the team sit down with Anita Gandhi, BMS, to explore the last decade in hematology and what lies ahead.

Omnichannel engagement expert Yacin Marzouki joins the show to share his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals. 

Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.

Look back on Season 9’s GOLD Medal Moments with the team before Season 10 begins.

Dr Dennise Broderick, President and Managing Director, Galen Pharma joins the GOLD podcast to discuss her life-long ambition to be a leader and how she approaches hard decisions in business. 

How can pharma navigate setbacks in drug development to deliver breakthroughs in R&D? Find out from Christoph von der Goltz, Boehringer.

Rebecca Vermeulen, recipient of the HBA STAR award for 2025 joins the podcast to discuss what effective patient centricity looks like and more.

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. 

Discover what’s on the horizon for cardiac care and remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.

Mary Stutts, CEO, HBA, unpacks the key findings of a report exposing critical gaps in doctors’ understanding of women’s health.

Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.

Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space

A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the series just gone?

Elias Revonta, Founder & CEO, Orcason Medical, joins the podcast to discuss why the fight against AMR needs to extend beyond awareness weeks.

Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.

Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.

Jennifer Schranz, SVP and Global Head of Rare Diseases, Ipsen, joins the podcast to discuss the burden faced by women with rare diseases.

Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.

Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.

Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.

Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.

The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7?

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.

The team explores how the industry may be missing out on insights from HCPs and hears from Robert Tegge, Associate Principal, ZS, who shares valuable insights on congresses.

Dr Harmony Garges, Chief Medical Officer, ViiV Healthcare, discusses how best to serve patients of all ages living with HIV around the world.

Danie du Plessis, Executive Vice President, Pharmaceutical Operations, Kyowa Kirin, talks about patient partnerships will need to evolve with a changing world, the future of medical affairs and more.

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, unpicks the current small molecule funding landscape, how to improve incentives to invest in rare diseases and more.

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Isabel is joined by Tim Uden, Creative Director, EMJ to discuss the new frontier of medical education tools and skills – interactive content.

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.

Mercedes Diz, Chief Marketing Officer, Almirall, talks about pushing your limits to achieve your goals and how to be more patient centric.

This special episode features three of last year’s guests, who share their predictions for the pharmaceutical industry’s year ahead.

Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals. 

Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.

In this episode of GOLD Podcast, Isabel brings you a curated selection of insights from the pharma leaders we have heard from so far. Listen now!